Travoprost/timolol, sold under the brand name Duotrav among others, is a fixed-dose combination medication used for the treatment of glaucoma.[4][5][6][7] It contains travoprost and timolol maleate.[4]

Travoprost/timolol
Combination of
TravoprostProstaglandin analog
TimololBeta-blocker
Clinical data
Trade namesDuotrav
AHFS/Drugs.comUK Drug Information
Pregnancy
category
Routes of
administration
Eye drops
ATC code
Legal status
Legal status
Identifiers
CAS Number
KEGG

It was approved for medical use in the European Union in April 2006.[4]

References

edit
  1. ^ a b "Travoprost/timolol Product Information" (PDF). TGA eBS. Retrieved 23 May 2021.
  2. ^ "DUOTRAV travoprost 0.004% and timolol 0.5% (as maleate) eye drop solution". Department of Health. Australian Government.
  3. ^ "DuoTrav eye drops solution - Summary of Product Characteristics (SmPC)". (emc). 14 June 2018. Retrieved 30 October 2020.
  4. ^ a b c d "Duotrav EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 30 October 2020.
  5. ^ Cheng JW, Cheng SW, Gao LD, Lu GC, Wei RL (2012). "Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis". PLOS ONE. 7 (9): e45079. Bibcode:2012PLoSO...745079C. doi:10.1371/journal.pone.0045079. PMC 3441590. PMID 23028770.
  6. ^ Konstas AG, Quaranta L, Realini T (April 2012). "Overview of the [corrected] travoprost /timolol BAK-free fixed combination". Expert Opinion on Pharmacotherapy. 13 (5): 757–66. doi:10.1517/14656566.2012.662485. PMID 22360540. S2CID 24160793.
  7. ^ Denis P (February 2011). "Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review". Expert Opinion on Pharmacotherapy. 12 (3): 463–71. doi:10.1517/14656566.2011.551007. PMID 21254951. S2CID 46258207.
edit